Viewing nowTelmisartan 40 mg Tablets
Telmisartan 40mg
Tablet · Prescription medication
Sam-il Pharmaceutical Co., Ltd.

MFDS item code 201001683 · Notified 2010.02.25 · Insurance code 643902880
Treatment of essential hypertension; reduction and prevention of cardiovascular disease risk
This medicine is used to effectively control blood pressure in patients with essential hypertension. Additionally, it helps reduce the risk of cardiovascular diseases, such as coronary artery disease, peripheral artery disease, and stroke, in high-risk patients aged 55 years and older who cannot use ACE inhibitors, and lowers the mortality rate due to myocardial infarction or stroke. It plays an important role in reducing the risk of cardiovascular diseases, thus maintaining patient health and improving quality of life.
1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. The maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. This medicine produces an additional blood pressure-lowering effect when coadministered with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that 80 mg of this medicine be administered orally once daily with water, with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg is unknown. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment and do not exceed 40 mg once daily.
This medication can cause severe damage or even death to the fetus or newborn if administered to pregnant women, so treatment should be stopped immediately upon confirmation of pregnancy. It should not be used in individuals with known allergic reactions to this drug, pregnant or breastfeeding women, those with severe liver impairment, patients with certain hereditary angioedema, and patients with diabetes or severe renal impairment. Elderly patients or those with high serum potassium levels, mild liver impairment, cardiovascular diseases, gastrointestinal diseases, renal artery hypertension, and severe renal impairment should use this medication cautiously. Various side effects may occur during treatment, including infections, blood abnormalities, allergic reactions, hyperkalemia, hypoglycemia, neurological abnormalities, arrhythmias, hypotension, respiratory difficulties, gastrointestinal disorders, liver dysfunction, skin rashes, muscle pain, and renal impairment. Immediate consultation with a physician is necessary if any unusual symptoms appear. Particular attention should be paid to conditions such as excessively low blood pressure, liver dysfunction, worsening renal function, severe allergic reactions, angioedema, interstitial pneumonia, and rhabdomyolysis. Patients with impaired renal function should have their serum potassium and creatinine levels regularly monitored, and those with volume depletion or sodium deficiency should improve their condition before administration to prevent hypotensive symptoms. Caution is required if taken with other medications affecting the renin-angiotensin-aldosterone system, as the risk of hypotension, hyperkalemia, and renal function deterioration may increase and should be closely monitored by healthcare professionals during concomitant use. It is advisable not to take this medication for 24 hours before surgery, and caution should be exercised in patients with gastrointestinal disorders due to the risk of gastrointestinal bleeding. This medication may cause dizziness or fainting while driving or operating machinery, and it should not be used in patients with fructose intolerance due to the presence of sorbitol. Women who are pregnant or planning to become pregnant should not use this medication, and breastfeeding women are advised to discontinue breastfeeding while taking this medication. It is not recommended for children under 18 years of age, as safety and effectiveness have not been established. In the case of overdose, hypotension, arrhythmias, dizziness, or renal failure may occur, so immediate medical attention is necessary, and blood pressure and renal function should be monitored frequently. This medication should be stored out of reach of children and kept sealed until administration.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. The recommended storage temperature is room temperature between 1 and 30 degrees Celsius.
White or nearly white, round, biconvex tablet
10 tablets/blister X 3, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTelmisartan 40mg
Tablet · Prescription medication
Sam-il Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Genewon Science Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Genuwon Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.